Biophysical Assays, Disease and Screening Hits

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

The challenge of GPCR drug discovery G protein-coupled receptors (GPCRs) are one of the most desirable and challenging target classes in drug discovery, as their mutation can lead to a wide range of diseases such as cancer, cardiovascular disorders and neurological conditions.

Fragment Screening

Fragment Screening Drugs Small Molecule Biophysical Assays

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

Webinars

Stay Connected